Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.11    
    

CONFIDENTIAL TREATMENT REQUESTED

[QUALLION
LOGO] 

PROPOSAL COVER SHEET  

 CUSTOMER INFORMATION  

	Company:	 	DexCom Inc.
	

Contact Person:	
 	

Mr. Jim Brauker, Vice President of R&D
	

Phone Number:	
 	

[*****]
	

Fax Number:	
 	

[*****]
	

Address:	
 	

6725 Mesa Ridge Road, Suite 100, San Diego, CA 92121
	
PROPOSAL SUMMARY
	

Proposal No.:	

 	

356 Rev. C
	

Title:	
 	

Development of Implantable Lithium Primary Battery for Continuous Glucose Sensor Devices
	

Submission Date:	
 	

May 21st, 2003
	

Expiration Date:	
 	

30 days
	

Contact Person:	
 	

Naoki Ota, Sr. Manager of Technologies and Applications Development
	

Contact Numbers:	
 	

[*****]
	

 	
 	

[*****]
	

Content:	
 	

X    I. Scope of Work
	

 	
 	

X    II. Schedule & Pricing
	

 	
 	

X    III. Contingencies
	

 	
 	

X    IV. Specifications & Qualification Plan
	

 	
 	

       IV. Drawings
	

 	
 	

X    VI. Terms & Conditions
	

 	
 	

       Other:
                                         
       

PROPOSAL ACCEPTANCE  

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

	Quallion LLC	 	DexCom Inc.
	 	 	 
	 	 	 
	/s/  WERNER HAFELFINGER      
 Werner Hafelfinger

President	 	/s/  JIM BRAUKER      
 Jim Brauker

Vice President of R&D
	 	 	 
	 	 	 
	 	 	/s/  STEVE KEMPER      
 Steve Kemper

Chief Financial Officer
	 	 	 
	 	 	 
	CONFIDENTIAL	 	Proposal No. 356 Rev. C
	Page 1 of 6

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

[QUALLION LOGO] 

I. SCOPE OF WORK  

        This proposal is for the design, development and manufacture of a lithium primary cell ("Cell") with the following model number: 

QC0025B  

        The product is designed for use in the following Customer's Device(s): 

Implantable Continuous Glucose Sensor System  

        For the following application: 

Glucose Monitoring  

        Quallion's proposal is based on the specification and qualification protocol provided by the Customer as defined in section IV, Specifications &
Qualification Plan. 

	CONFIDENTIAL	 	Proposal No. 356 Rev. C
	Page 2 of 6

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

[QUALLION LOGO] 

II. SCHEDULE & PRICING  

DEVELOPMENT:

	Item Description
 
	 	Qty
	 	Timeline
	 	Unit

Price
	 	Total

	Phase I: R&D Engineering Cells	 	[*****]	 	[*****]	 	[*****]	 	[*****]
	Phase II: Prototype Cells	 	[*****]	 	[*****]	 	[*****]	 	[*****]
	 	TOTAL	 	 	 	 	 	 	 	[*****]

PRODUCTION:

	Item Description
 
	 	Qty
	 	Timeline
	 	Unit

Price
	 	Total

	First Articles (Limited Qualifications)(1)	 	[*****]	 	[*****]	 	[*****]	 	[*****]
	 	TOTAL	 	 	 	 	 	 	 	[*****]

NRE:

	Item Description
 
	 	Qty
	 	Timeline
	 	Unit

Price
	 	Total

	NRE & Small Tooling	 	[*****]	 	[*****]	 	[*****]	 	[*****]
	 	TOTAL	 	 	 	 	 	 	 	[*****]

Production capacity scale-up plan:  

	1)
	Small-production:

	a.
	Maximum
capacity of [*****] units/month, established [*****] after execution

	b.
	of
development work stated in this proposal.

	c.
	Order
lead-time: [*****]

	d.
	Minimum
order: [*****] 

	i.	 	[****]	 	[*] / cell
	ii.	 	[****]	 	[*] / cell
	iii.	 	[****]	 	[*] / cell

	2)
	Scale-up
production:

	a.
	advanced
notification from Customer required.

	b.
	Additional
fee may apply for production tooling to support scale-up effort.

	c.
	Pricing
configuration 

	i.	 	[****]	 	[*] / cell
	ii.	 	[****]	 	[*] / cell
	iii.	 	[****]	 	[*] / cell

        Price
to be reviewed by September 2003 

	(1)
	First
Articles are provided with limited qualification testing. 

	CONFIDENTIAL	 	Proposal No. 356 Rev. C

        Page
3 of 6 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

[QUALLION LOGO] 

III. CONTINGENCIES  

This
proposal is effective upon: 

	1)
	Customer's
approval and signed acceptance of proposal prior to proposal expiration date.

	2)
	Quallion's
receipt of Customer Purchase Order per the Terms & Conditions listed in section VI. 

The
successful execution of deliverables is contingent upon: 

	1)
	Customer's
approval and signed acceptance of Product Specification and Qualification Plan within 30 days after execution of Proposal. 

	CONFIDENTIAL	 	Proposal No. 356 Rev. C

        Page
4 of 6 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

[QUALLION LOGO] 

IV. SPECIFICATIONS & QUALIFICATION PLAN  

Please
see attached documents: 

	1)
	Product
Specification for QC0025B (#PS0013 Rev.2)

	2)
	Customer
Requirement of QC0025B for DexCom (#300456 Rev.2)

	3)
	Qualification
Plan for QC0025B 

V. DRAWINGS  

NONE
APPLICABLE 

	CONFIDENTIAL	 	Proposal No. 356 Rev. C

        Page
5 of 6 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

[QUALLION LOGO] 

VI. TERMS & CONDITIONS  

Delivery:  

Work
will start on the first day after receipt of a written purchase order and follow the timeline shown in Section II, Schedule & Pricing. 

Payment terms:  

	Tooling & NRE	 	[*****]	 	Down payment with written purchase order
	 	 	[*****]	 	30 days after delivery of First Articles
	

Qualified Cell Purchases:	
 	

[*****]	
 	

Down payment with purchase order
	 	 	[*****]	 	Net 30 days after delivery of cells

Others:  

	1)
	If
Customer desires to make any modifications to the Cell specification, such modifications may be proposed to Quallion in writing and Quallion shall give such proposal its prompt
attention. Quallion will respond to Customer's proposed modifications by estimating the effect, if any, of proposed modifications on Cell performance, manufacturability, terms of delivery and
warranty. All modifications to Cell specifications shall be documented through an appropriate amendment signed by both parties.

	2)
	[*****]

	3)
	Quallion
will retain all rights to intellectual property it develops in connection with this project.

	4)
	Please
see attached Quallion's general Terms & Conditions of Sale. 

	CONFIDENTIAL	 	Proposal No. 356 Rev. C

        Page
6 of 6 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

Quallion LLC

Terms and Conditions of Sale 

Applicable Terms and Conditions  

All
Quallion products and services are furnished only on the temp and conditions stated herein and on the face of the applicable Quallion quotation to the exclusion of any Buyer terms and conditions
in any specific order documentation, preprinted or otherwise, except as to identification and quantity of products and services. Quallion's performance on an contract is expressly conditioned on
Buyers acceptance of Quallion's terms and conditions of sale. In the absence of such an agreement, performance shall be for the convenience of the Buyer only and shall not create any contractual
obligation or constitute acceptance by Quallion of any terms and conditions of the Buyer, printed or stated in its order. Buyer's acceptance of any product or service shall constitute acceptance of
Quallion's terms and conditions as stated herein. 

Orders, Quotations and Prices  

Quallion's
prices, quotations, and contracts for products and services are subject to the following unless otherwise slated in the applicable Quallion quotation or other writing signed by an
authorized representative of Quallion. In case of contradictory terms slated herein and on the face hereof; the latter shall control. 

	a.
	All
purchase orders are subject to written acceptance by Quallion.

	b.
	Acceptance
of purchase orders are expressly conditioned on compliance with all applicable laws, codes and regulations affecting the products and services

	c.
	Unless
otherwise stated on the applicable quotation, all quotations shall be considered solicitations for offers to purchase and shall neither constitute firm pricing or obligate
Quallion in any way.

	d.
	All
prices quoted are for products and services only, and shall exclude, and Buyer shall be responsible for, ordinary and necessary charges inured by Quallion and billed to Buyer.
These include, but are not limited to any and all applicable taxes, shipping charges, special packaging or insurance, incurred on Buyers instructions.

	e.
	Prices
quoted are for products and services only, and do not include rights to intellectual property, know-how, technology, patents, trademarks, copyrights, or other
proprietary rights

	f.
	Products
and services provided in accordance with Buyer's specifications, which are then changed by Buyer after quotation by Quallion or order placement, will be subject to
corresponding changes in price and delivery as determined by Quallion. 

Terms of Payment  

Unless
different terms of payment are stipulated on the Quallion quotation, payment of any services, engineering charges or tooling charges is due at the time of order placement. Payment for products
is due on shipment. Partial shipments if requested or authorized by the Buyer will be billed as a percent completion, which payment will be due on the partial shipment. 

Transportation and Risk of Loss  

All
shipping will be FOB Quallion's plant, and risk of loss or damage to products shall pass upon delivery to the transportation company. Quallion may, but is not obligated to insure to full value of
product shipped at Buyers expense and declare full value to the transportation company at time of shipment. Buyer shall inspect all products upon receipt and file all claims with the transportation
company and with Quallion when there is damage, external or concealed. 

Performance  

Quallion
shall not be liable for any delay in delivery or other performance which is due to unforeseen circumstances or to causes beyond its control, including, but not limited to strike, lockout,
riot, war, fire, flood, earthquake, acts of God, accident, failure or breakdown of components necessary to order completion, supplier, subcontractor, inability to obtain or substantial increases in
the cost of labor, materials or manufacturing facilities, curtailment of or failure to obtain sufficient electrical or other energy supplies; technical difficulties, or compliance with any
governmental law, regulation or order, including but not limited to US Export Administration Regulations or Buyer caused delays. Provided any such delay is not indefinite, performance shall be deemed
suspended during and extended for such a time as it is so delayed, and thereafter the Buyer shall accept performance. Delay in performance shall not be considered indefinite unless it exceeds or is
reasonably estimated to exceed six (6) months. 

Acceptance  

The
furnishing of a product or service by Quallion to the Buyer shall constitute acceptance of that product by Buyer, unless notice of defect or nonconformity is received by Quallion within thirty
(30) days of delivery of product at Buyers designated delivery address. Notwithstanding the above, any use, sale or other disposition of a product by Buyer, its agents, employees, contractors
or licensees, for any purpose after its receipt, shall constitute acceptance of the product by the Buyer. 

Assignments and Terminations  

No
order accepted by Quallion may be terminated, cancelled, modified or assigned except through mutual agreement in writing. Any attempt to do so without Quallion's written consent shall be void. 

Warranty  

All
products are warranted to meet Quallion's specifications, including Buyer's specifications, if any, which have been agreed upon in writing by Quallion. Products are not warranted to meet Buyer's
specifications or
changes to specifications not agreed upon in writing by Quallion. Products are not warranted unless Quallion receives written notice within 30 says after shipment describing the products' failure to
meet specifications, in which event, Quallion will decide whether to replace the products or refund any payment received for the product. Quallion makes no warranties except as herein specified, and
all other warranties are expressly excluded. 

Damages and Liability  

QUALLION'S
TOTAL LIABILITY IN DAMAGES OR OTHERWISE SHALL NOT EXCEED THE PAYMENT, IF ANY, RECEIVED BY QUALLION FOR THE UNIT OR PRODUCT OR SERVICE FURNISHED OR TO BE FURNISHED, AS THE CASE MAY BY,
RESULTING IN THE LOSS OR DAMAGE CLAIM. IN NO EVENT SHALL QUALLION BE LIABLE FOR INCIDENTAL. CONSEQUENTIAL, INDIRECT, PUNITIVE OR SPECIAL LOSS OR DAMAGES OF ANY KIND, SUCH AS, BUT NOT LIMITED TO, LOST
BUSINESS REVENUE, LOST PROFITS OR COSTS OF DOWNTIME RESULTING FROM QUALLION'S PRODUCTS OR SERVICES, HOWEVER CAUSED, WHETHER BASED ON CONTRACT, TORT (INCLUDING NEGLIGENCE) OR ANY OTHER LEGAL THEORY. 

Indemnities  

Notwithstanding
any fault or negligence attributable to Quallion, Quallion shall have no responsibility whatsoever for, and Buyer shall indemnify, defend, and hold Quallion harmless from any and all
damage or injury to persons or property which may arise from or relate to 1) any use, operation, or service of any product contrary to any written warning or instruction given by Quallion with
respect to such product, including, but not limited to unauthorized use and/or modification of said product by the user, or 2) an liability for Buyer with respect to OSHA toxic substances, air
quality, water quality, hazardous waste, Superfund for other environmental liability including, but not limited t fines, penalties, cleanup costs or tort related, to the use, operation, or service or
any product, or 3) the design. manufacture, purchase. sale use or reuse of any Product provided as convenience to the Buyer but not manufactured by Quallion and not listed as a Quallion product
in a sales quotation or other official Quallion documentation. 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

	Revision
 
	 	Description
	 	DAR Number
	 	Prepared By
	 	Release Date

	1	 	PROTOTYPE RELEASE	 	B1365	 	KG	 	[*****]
	2	 	SEE DAR	 	B	 	 	 	 

CUSTOMER REQUIREMENT OF QC0025B FOR DEXCOM  

	Prepared By:	 	[*****]	 	Date:	 	[*****]	 	[QUALLION LOGO]
	Checked By:	 	[*****]	 	Date:	 	[*****]	 	 	 	 
	Approved By:	 	[*****]	 	Date:	 	[*****]	 	Number	 	300456
	Next Assy:	 	 	 	Model No.	 	QC0025B	 	Sheet	 	1 of 3

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

1.0 PURPOSE

This
document defines the requirements for a lithium primary cell to be shipped to DexCom by Quallion LLC. 

2.0 SCOPE

This
document applies to the QC0025B product. 

3.0 REFERENCE DOCUMENTS

PS
0013 Product Specification, QC0025B 

4.0 DEFINITIONS

[*****]

	[QUALLION LOGO]	 	Doc. No. 300456	 	Sheet 2 of 4	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

[*****]

5.0 RESPONSIBILITIES

[*****]

6.0 GENERAL REQUIREMENTS

[*****]

	[QUALLION LOGO]	 	Doc. No. 300456	 	Sheet 3 of 4	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

[*****]

	[QUALLION LOGO]	 	Doc. No. 300456	 	Sheet 4 of 4	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

	Revision
 
	 	Description
	 	DAR Number
	 	Prepared By
	 	Release Date

	1	 	PROTOTYPE RELEASE	 	B1364	 	KG	 	[*****]
	2	 	SEE DAR	 	B	 	 	 	 

PRODUCT SPECIFICATION,

QC0025B  

	Prepared By:	 	[*****]	 	Date:	 	[*****]	 	[QUALLION LOGO]
	Checked By:	 	[*****]	 	Date:	 	[*****]	 	 	 	 
	Approved By:	 	[*****]	 	Date:	 	[*****]	 	Number	 	PS 0013
	Next Assy:	 	 	 	Model No.	 	QC0025B	 	Sheet	 	1 of 10

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

1.0 PURPOSE

This
specification defines the requirements for a custom lithium primary cell to be shipped to the customer by Quallion LLC. 

2.0 SCOPE

This
document applies to the QC0025B product. 

3.0 REFERENCE DOCUMENTS

	 	3.1. MIL-STD-883	 	Test Methods Stand: Microcircuits
	 	3.2. ISTA	 	International Safe Transit Association
	 	3.3. I50-9000	 	International Organization for Standardization: Quality Management
	 	3.4. MIL-STD-202F	 	Test Method for Electrical and Electronic Component Parts
	 	3.5. EN45502-1	 	Active Implantable Medical Devices, Part 1
	 	3.6. TM 0006	 	Micronail Penetration Test, Quallion LLC
	 	3.7. UL1642	 	Standard for Safety: Lithium Batteries, 3rd edition

	

[QUALLION LOGO]	
 	

Doc. No. PS 0013	
 	

Sheet 2 of 10	
 	

Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

4.0 DEFINITIONS

[*****]

	[QUALLION LOGO]	 	Doc. No. PS 0013	 	Sheet 3 of 10	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

5.0 CELL REQUIREMENTS

[*****]

	5.2.
	Mechanical

	PROPERTIES
 
	 	Conditions
	 	REQUIREMENT

	Dimensions	 	[*****]	 	[*****]
	Weight	 	[*****]	 	[*****]
	Case Material	 	[*****]	 	[*****]
	Case Polarity	 	[*****]	 	[*****]
	Positive Feedthru Material	 	[*****]	 	[*****]
	Negative Feedthru Material	 	[*****]	 	[*****]
	Cell Marking	 	[*****]	 	[*****]
	Cell Hermeticity	 	[*****]	 	[*****]
	Feedthru Pin Strength	 	[*****]	 	[*****]

	[QUALLION LOGO]	 	Doc. No. PS 0013	 	Sheet 4 of 10	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

5.3.
Electrochemical 

	PROPERTIES
 
	 	CONDITIONS
	 	REQUIREMENT

	Capacity	 	[*****]	 	[*****]
	Average Voltage	 	[*****]	 	[*****]
	Normal Operating Voltage Range	 	[*****]	 	[*****]
	Operating Discharge Temperature	 	[*****]	 	[*****]
	Preferred Storage Temperature	 	[*****]	 	[*****]
	Discharge Current	 	[*****]	 	[*****]
	Discharge Pulse Current	 	[*****]	 	[*****]
	AC Impedance	 	[*****]	 	[*****]

	[QUALLION LOGO]	 	Doc. No. PS 0013	 	Sheet 5 of 10	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

5.4.
Environment 

	PROPERTIES
 
	 	CONDITION
	 	REQUIREMENT

	Vibration Test	 	[*****]	 	 
	Mechanical Shock Test	 	[*****]	 	 
	Drop Test	 	[*****]	 	 
	Altitude Test	 	[*****]	 	[*****]
	Temperature Shock Test	 	[*****]	 	 
	Humidity Test	 	[*****]	 	 
	High Temperature Storage	 	[*****]	 	 
	Low Temperature Storage	 	[*****]	 	 

5.5.
Safety 

	PROPERTIES
 
	 	CONDITION
	 	REQUIREMENT

	External Short	 	[*****]	 	[*****]
	Over Discharge	 	[*****]	 	[*****]
	Crush	 	[*****]	 	[*****]
	Impact	 	[*****]	 	[*****]
	Hot Box	 	[*****]	 	[*****]
	Nail Penetration	 	[*****]	 	[*****]

	[QUALLION LOGO]	 	Doc. No. PS 0013	 	Sheet 6 of 10	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

6.0 SHIPPING AND STORAGE

[*****]

7.0 NOTIFICATION OF CHANGES

	7.1.
	Quallion
LLC shall notify Customer of any changes in manufacturing processes, testing, raw materials, or design that affect form, interchangeability, reliability, packaging,
labeling, storage condition, fit or function so that the customer is able to evaluate the possible effects of such changes in its application. None of the changes specified above shall be made without
prior written permission from the customer. 

8.0 QUALITY ASSURANCE SYSTEM REQUIREMENT

	8.1.
	The
cell is to be manufactured within a documented system in general accordance with the requirements of ISO-9000. The Customer has the right to periodically audit Quallion LLC for
compliance to this requirement 

9.0 PACKAGING

	9.1.
	Each
cell shall be packaged in such a manner as to be protected from physical damage, contamination, or short-circuiting when subjected to ISTA procedure 1A.

	9.2.
	The
cell shall be free of oils, grease, or ionic contamination.

	9.3.
	The
feedthrus shall be protected from damage by means of plastic covers. 

10.0 RETAINED SAMPLES

	10.1.
	[*****]

	10.2.
	[*****]

	10.3.
	[*****] 

11.0 DATA PACKAGE REQUIREMENT

	11.1.
	[*****]

	[QUALLION LOGO]	 	Doc. No. PS 0013	 	Sheet 7 of 10	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

Appendix I  

 Test Procedures  

[*****]

	[QUALLION LOGO]	 	Doc. No. PS 0013	 	Sheet 8 of 10	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

Appendix II

Customer Requirement  

DOCUMENT #

300456  

	[QUALLION LOGO]	 	Doc. No. PS 0013	 	Sheet 9 of 10	 	Rev. 2

This
document, and any attachment, contains CONFIDENTIAL and PROPRIETARY information that is the property of Quallion LLC. This document and the information herein may not, in whole or in part, be
duplicated, disclosed, or used for design, manufacturing, or other purposes without the prior written permission of Quallion LLC 

300181,
Rev. A 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

[*****]

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

QUALIFICATION PLAN  

	Date:	 	May 21st, 2003	 	 
	Customer Name	 	DexCom Inc.	 	 
	Product:.	 	QC0025B	 	 
	Revision:	 	C	 	 
	Reference Document:	 	Product Specification for QC0025B, Doc.    PS0013

Customer Requirement, Doc.            300456	 	 

STANDARD TESTING (per PS 0013)  

	REF
 
	 	SPECIFICATION
 
	 	[*****]
	 	[*****]
	 	[*****]
	 	Other

	5.2	 	Mechanical	 	 	 	 	 	 	 	 
	 	 	[*****]	 	X	 	 	 	 	 	 
	 	 	[*****]	 	X	 	 	 	 	 	 
	 	 	[*****]	 	X	 	 	 	 	 	 
	 	 	[*****]	 	X	 	 	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	5.3	 	Electrochemical	 	 	 	 	 	 	 	 
	 	 	[*****]	 	X	 	 	 	 	 	 
	 	 	[*****]	 	X	 	 	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	 	 	[*****]	 	X	 	 	 	 	 	 
	5.4	 	Environment	 	 	 	 	 	 	 	 
	 	 	[*****]	 	 	 	 	 	X	 	 
	 	 	[*****]	 	 	 	 	 	X	 	 
	 	 	[*****]	 	 	 	 	 	X	 	 
	 	 	[*****]	 	 	 	 	 	X	 	 
	 	 	[*****]	 	 	 	 	 	X	 	 
	 	 	[*****]	 	 	 	 	 	 	 	X
	 	 	[*****]	 	 	 	 	 	 	 	X
	 	 	[*****]	 	 	 	 	 	X	 	 

CONFIDENTIAL  

Page
1 of 3 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

	5.5	 	Safety	 	 	 	 	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	 	 	[*****]	 	 	 	X	 	 	 	 
	 	 	[*****]	 	 	 	 	 	X	 	 
	 	 	[*****]	 	 	 	 	 	X	 	 
	 	 	[*****]	 	 	 	 	 	X	 	 
	6.0.	 	Shelf Life	 	 	 	 	 	 	 	X
	9.0	 	Packaging (ISTA)(3)	 	 	 	 	 	X	 	 

CONFIDENTIAL  

Page
2 of 3 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

STANDARD TESTING (per 300456)  

	REF
 
	 	SPECIFICATION
 
	 	6/9/2003
	 	9/9/2003
	 	12/9/2003
	 	Other

	 	 	[*****]	 	 	 	[*****]	 	 	 	 
	 	 	[*****]	 	 	 	 	 	 	 	[*****]
	 	 	[*****]	 	 	 	 	 	 	 	[*****]
	 	 	[*****]	 	 	 	 	 	[*****]	 	 

CONFIDENTIAL  

Page
3 of 3 

* CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN OMITTED AND THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE SEC. CONFIDENTIAL TREATMENT
HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. 

QuickLinks

Exhibit 10.11QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.1    
    

February 14,
2005 

Christopher J. Coughlin  

Dear
Chris: 

        I
am pleased to offer you the position of Executive Vice President and Chief Financial Officer, Tyco International Ltd., with all the duties, authorities and responsibilities
commensurate with such role. You will report to me and will be based in Princeton, New Jersey. Your employment will begin on a mutually agreeable start date, which we anticipate to be on or about
March 7, 2005. Your compensation and benefits are described below: 

Compensation  

        You will receive a monthly salary of $62,500 ($750,000 annualized). Your salary will be paid monthly, in the month that it is earned. In addition to your base
salary, you will be eligible to participate in the Company's annual incentive plan and long-term incentive program. Additionally, you will receive a sign-on bonus of $100,000
to be paid as soon as administratively possible after your employment start date. 

        Under
the annual incentive plan you will have the opportunity to earn a target award of 100% of your salary and a maximum award of 200% of your salary, prorated for fiscal year 2005.
Determination of award levels will be based on the Company's financial performance and your individual contribution. 

        As
stated above, you will also be eligible for the Company's long-term incentive program. You will be nominated for a FY2005 option grant to purchase of 250,000 shares of the
Company's common stock and a FY2005 restricted stock grant of 60,000 shares, on the later of your start date or the time the Company makes its annual grant (expected to occur on or about
March 10, 2005), subject to approval by the Board of Directors. The exercise price of option grants is based on the average of the high and low price of the stock on the date of grant. The
options will vest equally (1/3 on each anniversary of the grant date) over the three (3) year period commencing immediately following the grant date and the restricted shares
cliff-vest on the third anniversary of the grant date. You will receive more information about your awards, detailing the terms and conditions, after they have been granted. 

Sign-on Option and Restricted Stock Grant  

        On your start date, you will receive a sign-on option grant to purchase 100,000 shares of the Company's common stock and a sign-on
restricted stock grant of 40,000 shares. The exercise price of the option grants is based on the average of the high and low price of the stock on the date of grant, which will be your start date with
the Company. The options will vest equally (1/3 on each anniversary of the grant date) over a three (3) year period commencing immediately following your start date and the
restricted shares cliff-vest on the third anniversary of your start date. You will receive more information on your awards, detailing the terms and conditions, immediately following your
start date. 

Flexible Perquisite Program  

        You will also be eligible to participate in the Flexible Perquisite Plan, which allows for an annual sum paid in quarterly installments that can be used at the
discretion of the participant to apply to various expenses. Your eligibility will begin with the first full quarter after your start date. Allowances are set at 10% of base annual salary, capped at
$70,000 annually, less applicable taxes. Examples of expenses covered under this plan are car leases, car payments or auto insurance, financial and estate planning, club memberships, executive
physicals and income tax preparation. 

Benefits  

        You will also be entitled to all employee benefits that Tyco customarily makes available to employees in positions comparable to yours. Specifically, you will be
eligible to participate in the following: 

	•
	Tyco Retirement Savings and Investment Plan—This 401(k) plan provides for retirement savings through employee
contributions and a five-to-one company matching contribution on the first one percent of your employee contribution. Approximately 30 days following your date of hire,
you will be automatically enrolled in this plan at a pretax contribution rate of 2% of your eligible compensation. You will have the opportunity to make changes within your first 30 days of
employment if you decide 

 

you
would like to increase or decrease your automatic enrollment pretax contribution rate. Additionally, catch up contributions are allowed for participants who qualify; however, Tyco does not match
these. You will be receiving an enrollment kit shortly where you can learn more about the features of this plan. 

	•
	Tyco Medical and/or Dental plans on a contributory basis 31 days after your employment start date. Benefit programs
are reviewed annually and changes in plan design and/or employee contributions are the norm and communicated in advance of any changes. A benefits packet, which includes specific information about
these benefits and others, will be forwarded to you.

	•
	Tyco Supplemental Savings and Retirement Plan—In addition to the 401(k) plan, Tyco also offers you another
opportunity to save money on a tax-deferred basis. This plan is the unfunded, non-qualified counterpart to the 401(k) plan, and allows you to defer up to 50% of your base
salary. To participate in this plan for 2005, you must enroll within 30 days of your date of hire. Your contributions to the plan will start as soon as administratively practicable following
your enrollment. Due to new rules governing non-qualified deferred compensation plans, the SSRP will only provide participants the opportunity to defer all or a portion of their bonus if
such deferral election is made prior to the start of the plan year, or for 2005, prior to March 15, 2005 for new hires. If you participate in this plan, you will receive company contributions
based on your deferred base salary and bonus at the same five-to-one matching rate you would be eligible to receive under the 401(k) plan, thereby providing you with the full
company contribution between both plans. If you choose not to participate, you will still receive company contributions to this plan on any cash compensation (i.e., base and bonus) during the year
that exceeds the IRS section 401(a)(17) limit ($210,000 in 2005). The investment options available under the SSRP are a subset of those that are available under the RSIP.

	•
	Supplemental Executive Benefits—As an Executive Officer of the Company, you will be eligible for the following
supplemental insurance benefits: (Participation is contingent upon individual insurability determinations.)

	•
	Variable Universal Life Insurance

This
program is designed to provide a permanent life insurance policy with cash value to each of our officers, with a death benefit of 2X base salary. Premiums are paid by the Company (and grossed up
for income taxes, as applicable) while you are actively employed as an officer. You direct investment of the cash value portion under the policy, within a list of funds offered by the insurer. The
policy is individually owned and therefore fully portable. 

	•
	Long Term Disability

This
policy is designed to increase the monthly disability income protection for each officer, from a maximum $10,000 per month (under the current Tyco Long-Term Disability program) to a
total maximum of $35,000 of monthly disability benefit available to age 65, with cost of living increases included in the coverage. Under the current program, $20,000 of monthly coverage is portable.
Premium payments are taxable income to you, but will be grossed up by Tyco. Disability is defined as inability to perform your own occupation, and includes mental and nervous disabilities. 

2

 

	•
	Long Term Care

Each
officer and his/her spouse will be covered for life for assisted living expenses provided by a licensed health care professional at the rate of $250 daily or $7,500 per month. Coverage is
individually owned and therefore fully portable. Under the current program, premium payments and benefit proceeds are tax-exempt. 

	•
	Tyco International (US) Inc. Severance Plan for U.S. Officers and Executives ("Severance Plan")—In the
event of an involuntary termination of your employment (other than for Cause, as defined in the Severance Plan as then in effect), you will receive the benefits provided under the terms of the
Severance Plan, which currently include two years base, target bonus, and continued medical and 12 months continued option vesting and option exercise period (but not beyond the option
expiration date). All severance benefit eligibility is contingent upon execution of a general release in favor of Tyco, a one-year non-competition, a two-year
non-solicitation and ongoing confidentiality and non-disparagement covenants. Unvested restricted stock and restricted stock units are forfeited on termination; provided,
however that your sign-on restricted stock will fully vest in the event of involuntary termination of employment, other than for Cause.

	•
	Tyco International (US) Inc. Change in Control Severance Plan for certain U.S. Officers and Executives ("CIC
Plan")—In the event of an involuntary termination (or resignation for Good Reason, as defined in the Plan) in connection with a Change in Control and occurring
within 60 days before or two years after a Change in Control (or upon resignation within 90 days following a "good reason" event)
you will be eligible for such benefits as may be provided under the terms of the CIC Plan, in lieu of Severance Plan benefits referred to in the immediately preceding paragraph. CIC Plan benefits
currently include 2.99 times salary and target bonus, with continued medical coverage during such period; accelerated option and restricted share vesting; and the full remaining option exercise term,
all subject to release of claims, non-competition, confidentiality, non-solicitation and non-disparagement provisions. Benefits payable to you under the CIC Plan
may be reduced as necessary to avoid IRS excise taxes if the after tax benefit to you is greater than it would have been had you received an unreduced amount, but no gross up is provided under the CIC
Plan.

	•
	Severance Plan and CIC Plan Changes. In the event that, after the date hereof, the Company amends the terms of the Severance
Plan or the CIC Plan for other senior officers of the Company, you shall be subject to the same terms and conditions and eligible for the same benefits as other similarly situated executives under
such plan(s).

	•
	Vacation—You will be eligible for four (4) weeks of vacation per year. 

Conditions of Employment  

        Your employment will be conditioned upon your execution of and ongoing compliance with the Company's Confidentiality and Development Agreement and the Company's
Guide to Ethical Conduct that are enclosed; and any other applicable Company policies. A W-4 and a direct deposit application are also enclosed. Please return these forms along with one
original signed copy of this letter to: Nicholas Brecker, Director, Executive Compensation, Tyco International (US) Inc., 9 Roszel Road, Princeton, NJ 08540, as soon as possible. 

        Non-Competition:    Because you will be performing services for the Company of such a unique and irreplaceable
nature, your performance of such services to a competing business would result in irreparable harm to the Company. Accordingly, by accepting this employment offer, you agree that during your
employment and for the one year period thereafter, you will not, directly or indirectly, own, manage, operate, control, or provide services to or be employed by any person or entity engaged in any
business of the same type as any business in which the Company or any of its subsidiaries or affiliates is engaged (or have proposed to be engaged) on the date of termination. It is understood,
however, that ownership of one percent of the total shares of all classes of stock outstanding of any publicly held entity engaged in such business and rendering of services to charitable
organizations, as such term is defined in Section 501(c) of the Code, shall not be considered to violate this non-competition provision. 

3

 

        Non-Solicitation:    By your acceptance of this employment offer, you also agree that during your employment with
the Company and for the two year period thereafter, you will not, directly or indirectly, on
your own behalf or on behalf of another, solicit, aid or induce any managerial level employee of the Company or any of its subsidiaries or affiliates to leave such employment in order to accept
employment with or render services to another person or entity or solicit, aid or induce any customer of the Company or any of its subsidiaries or affiliates to purchase goods or services then sold by
the Company or any of its subsidiaries or affiliates from another person or entity (or assist or aid any other persons or entity in identifying or soliciting any such customer). 

        Other Conditions:    In addition, the conditions of this letter are contingent upon the following: 

	1.
	Successful
completion of a drug test. You will be contacted to set up an appointment at a collection site convenient to you. The Company shall maintain the confidentiality of the
results of the drug testing.

	2.
	Documentation
of your identity and unrestricted legal authority to work in the United States. You will be required to complete the employee portion of the enclosed I-9
documentation as well as other documents within 3 business days of your hire date to satisfy those requirements. Please note that this is a legal
requirement under federal immigration laws. 

        Chris,
I am excited about the prospect of your joining the Tyco leadership team and I look forward to the opportunity to work with you. 

        Please
sign below to signify your acceptance of our offer of employment and its terms. Should you have any questions with regard to any of the items indicated above, please call me. 

Sincerely,

/s/
Edward D. Breen 

Edward D. Breen

Chairman and Chief Executive Officer

Tyco International Ltd.  

ACCEPTED: 

	

 	
 	

 
	/s/ Christopher J. Coughlin	 	2/14/2005
	

	Christopher J. Coughlin	 	Date

Employees have the right to terminate their employment at any time with or without cause or notice, and the Company reserves for itself an equal right. We both agree that any
dispute arising with respect to your employment, the termination of that employment, or a breach of any covenant of good faith and fair dealing related to your employment, shall be settled exclusively
through arbitration. This document sets forth the entire agreement with respect to your employment. The terms of this offer may only be changed by written agreement, although the Company may from time
to time, in its sole discretion, adjust the salaries and benefits paid to you and its other employees.

4

QuickLinks

Exhibit 10.1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00078-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00078-of-00352.parquet"}]]